药物信息为Paclitaxel Injection (Teva Parenteral Medicines, Inc): OVERDOSAGE
- WARNING
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- PRECAUTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- REFERENCES
- Patient Information
- PRINCIPAL DISPLAY PANEL - 5 mL Carton
- PRINCIPAL DISPLAY PANEL - 16.7 mL Carton
- PRINCIPAL DISPLAY PANEL - 25 mL Carton
- PRINCIPAL DISPLAY PANEL - 50 mL Carton
- 外部链接相关的Paclitaxel Injection (Teva Parenteral Medicines, Inc)
There is no known antidote for paclitaxel injection overdosage. The primary anticipated complications of overdosage would consist of bone marrow suppression, peripheral neurotoxicity, and mucositis. Overdoses in pediatric patients may be associated with acute ethanol toxicity (see PRECAUTIONS: Pediatric Use).
- Drug Information Provided by National Library of Medicine (NLM).
